SR One's new investment fund is its second one since spinning out of GSK in 2020. The firm says it now has more than $1.5 billion in assets under management.
Presented by Intelligent Medical Objects and MedCity News
Join us on April 11th for this webinar sponsored by Intelligent Medical Objects, which will explore how payers are meeting the needs of the 2016 21st Century Cures Act when it comes to providing unfettered access to structured medical data for members.
Many health system technology executives have found that a strong digital transformation strategy requires sustained cross-department collaboration. At a recent conference panel, tech executives from UPMC and LifeBridge Health discussed why partnerships with the marketing department and analytics team are essential.
Vertex Pharmaceuticals aims to CRISPR Therapeutics' gene-editing technology to develop type 1 diabetes cell therapies that don't prompt the immune system to reject them. This approach could compete with a Sana Biotechnology program expected to reach its first test in humans this year.
By evaluating the potential of healthcare operations software investments to affect each of these three key outcomes areas — patient outcomes, workforce outcomes, and risk and compliance outcomes — CIOs can make informed decisions that drive value and improve outcomes for patients, providers, and the entire organization.
No comments